Correction to: Circ-ASH2L promotes tumor progression by sponging miR-34a to regulate Notch1 in pancreatic ductal adenocarcinoma

Correction to: J Exp Clin Cancer Res 38, 466 (2019)

https://doi.org/10.1186/s13046-019-1436-0

Following publication of the original article [1], the authors identified some minor errors in image-typesetting in Fig. 4; specifically in Fig. 4a and Fig. 4h.

Fig. 4.

a-b The invasion abilities of indicate treated Capan-1 (a) and Aspc-1 cells (b) were measured by transwell assays. Scale bars = 50 μm. c-d The proliferation abilities of indicate treated Capan-1 (c) and Aspc-1 cells (d) were measured by EdU assays. Scale bars = 50 μm. e-g The indicate treated Aspc-1 and Capan-1 cells (e) were stained by propidium iodide and analyzed using flow cytometry, the statistical results of Aspc-1 (f) and Capan-1 (g) cells were showed in right column. h-i The in vitro angiogenesis abilities of indicated treated Capan-1 and Aspc-1 cells were measured by tube-formation assays of HUVECS cells (h), and the statistical result was showed in right column (i)

The corrected figure is given below. The correction does not have any effect on the results or conclusions of the paper.